CI
ABBV icon

Cowen Inc’s AbbVie ABBV Stock Holding History

Cowen Inc’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		$514K Buy
+206,800
New +$16.3M 0.04% 191
2015
Q4 		– Sell
-10,000
Closed -$544K – 294
2015
Q3 		$544K Buy
+10,000
New +$651K 0.03% 169
2014
Q3 		– Sell
-90,000
Closed -$5.08M – 298
2014
Q2 		$5.08M Buy
+90,000
New +$4.72M 0.57% 31

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AAMU
Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Cowen Inc's ABBV Position: Q2 2019 in Review

Cowen Inc sold out of AbbVie (ABBV) in Q2 2019, closing a stake of 10,750 shares — an estimated $845K sold.

Cowen Inc first reported a position in ABBV in Q3 2014 and held it in 6 quarters. The position peaked at $2.43M in Q2 2015. 2,020 funds tracked by Wall St. Rank hold ABBV as of Q2 2019.

  • Cowen Inc reported no remaining AbbVie position as of Q2 2019 after selling out during the quarter.
  • Cowen Inc sold 10,750 AbbVie shares in Q2 2019, an estimated $845K.
  • Cowen Inc first reported a position in AbbVie in Q3 2014 and held it in 6 quarters.
  • Cowen Inc's AbbVie position peaked at $2.43M in Q2 2015.
  • 2,020 funds tracked by Wall St. Rank held AbbVie as of Q2 2019.

Based on Cowen Inc's 13F filing for Q2 2019, filed 14 Aug 2019.